Physician

David J Spinak, MD

According to 2025 Medicare claims, David Spinak, MD (NPI: 1942232913) practices ophthalmology in the Bremerton-Silverdale-Port Orchard, WA market, with the plurality of this provider's patient population coming from Kitsap, WA. This provider's primary affiliated billing organization is PACIFIC NORTHWEST RETINA PLLC (NPI: 1558940387; TIN: 853763379) and primary practice location at 98383-7849.

Spinak's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,141 traditional Medicare patients, billed 54,885 HCPCS/CPT codes, and received $4,723,955 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 144 prescription claims across 67 beneficiaries totaling $6,282 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 8 records totaling $20,416. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $30,689 to $6,282. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.4M$4.7M2015 Medicare payment: $3,196,142 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,208,206 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,741,609 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,576,161 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,394,461 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,521,631 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,478,529 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,803,175 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,199,944 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,723,955 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201596817,178$3,196,142
20161,02017,706$3,208,206
20171,14718,136$3,741,609
20181,23517,631$3,576,161
20191,20017,209$3,394,461
20201,06316,436$3,521,631
20211,09916,508$3,478,529
20221,16122,820$3,803,175
20231,17949,333$4,199,944
20241,14154,885$4,723,955

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$15K$31K2015 Drug cost: $30,689 (USD; Tot_Drug_Cst)2016 Drug cost: $16,009 (USD; Tot_Drug_Cst)2017 Drug cost: $15,518 (USD; Tot_Drug_Cst)2018 Drug cost: $15,724 (USD; Tot_Drug_Cst)2019 Drug cost: $16,968 (USD; Tot_Drug_Cst)2020 Drug cost: $18,764 (USD; Tot_Drug_Cst)2021 Drug cost: $12,705 (USD; Tot_Drug_Cst)2022 Drug cost: $12,546 (USD; Tot_Drug_Cst)2023 Drug cost: $6,971 (USD; Tot_Drug_Cst)2024 Drug cost: $6,282 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201553174$30,689
201642150$16,009
201762192$15,518
201870197$15,724
201971170$16,968
2020106234$18,764
2021137249$12,705
202265173$12,546
202351128$6,971
202467144$6,282

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system426502$102
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more209233$101
67028Injection of drug into eye4612,148$98
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more6931,507$68
92134Imaging of retina1,0413,505$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate431,711$2,061
Diclofenac SodiumDiclofenac Sodium421,075$483
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha23500$263

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$242Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.6$20,174Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David J. Spinak, MD?

Tedicare shows public-source Medicare data for David J. Spinak, MD (NPI 1942232913), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David J. Spinak, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David J. Spinak, MD?

David J. Spinak, MD is linked to PACIFIC NORTHWEST RETINA PLLC (billing NPI 1558940387) in the available physician profile data.

Does David J. Spinak, MD have Open Payments data?

David J. Spinak, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.